2 tracked public figures made calls on PFE. We grade SELL/REDUCE calls as Correct/Incorrect/Pending, and compare BUY/ADD returns against the S&P 500 over matched windows.
On average, public BUY calls on Pfizer beat the S&P 500 by +15.2%.
| Who | Signal | Date | Return / Grade | Buy vs S&P | Source |
|---|---|---|---|---|---|
| Yung-Yu Ma | BUY | Sep 28, 2025 | +13.1% | -2.3% | source ↗ |
| Michael Burry | BUY | Nov 04, 2025 | +11.0% | -4.0% | source ↗ |
Yung-Yu Ma currently ranks #1 on PFE with +13.1% average buy return vs -2.3% for the S&P 500 (+15.4% alpha) across 1 scored buy calls.
Yes. Across 2 scored BUY/ADD calls, average return is +12.0% vs -3.1% for the S&P 500 (+15.2% alpha).
SELL/REDUCE calls are shown as Correct, Incorrect, or Pending. Only BUY/ADD calls are compared directly against the S&P 500 in the ticker-level return stats.